ResearcherHerlev HospitalActive in the last 2 years

I.M. Chen

Verified by OpenAlex author ID (good confidence, 0.85), identity_conf@1As of 7 November 2026

Matched on OpenAlex author ID A5089041728. Sources: OpenAlex.

Their work

Papers: 2 (first author 0, last author 1)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 9

Papers, trials and grants by year

2024: 1 paper · 2025: 1 paper

Papers 2

Elevated levels of cleaved soluble forms of urokinase-type plasminogen activator receptor are associated with poor survival in advanced pancreatic cancer. Co-author DOI 10.1016/j.ejca.2025.116095 ↗
Circulating immune-related proteins associated with immune checkpoint inhibitor efficacy in patients with pancreatic ductal adenocarcinoma. Last author DOI 10.1016/j.esmoop.2024.103489 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Dan Calatayud · 1 shared paper, 2025 · strength 0.26
- Paper Elevated levels of cleaved soluble forms of urokinase-type plasminogen activator receptor are associated with poor surv… DOI 10.1016/j.ejca.2025.116095 ↗
Astrid Zedlitz Johansen · 1 shared paper, 2025 · strength 0.26
- Paper Elevated levels of cleaved soluble forms of urokinase-type plasminogen activator receptor are associated with poor surv… DOI 10.1016/j.ejca.2025.116095 ↗
Gunilla Høyer‐Hansen · 1 shared paper, 2025 · strength 0.26
- Paper Elevated levels of cleaved soluble forms of urokinase-type plasminogen activator receptor are associated with poor surv… DOI 10.1016/j.ejca.2025.116095 ↗
Rikke Løvendahl Eefsen · 1 shared paper, 2025 · strength 0.26
- Paper Elevated levels of cleaved soluble forms of urokinase-type plasminogen activator receptor are associated with poor surv… DOI 10.1016/j.ejca.2025.116095 ↗
Per Pfeiffer · 1 shared paper, 2025 · strength 0.26
- Paper Elevated levels of cleaved soluble forms of urokinase-type plasminogen activator receptor are associated with poor surv… DOI 10.1016/j.ejca.2025.116095 ↗
Susann Theile · 1 shared paper, 2024 · strength 0.22
- Paper Circulating immune-related proteins associated with immune checkpoint inhibitor efficacy in patients with pancreatic du… DOI 10.1016/j.esmoop.2024.103489 ↗
Sidsel C. Lindgaard · 1 shared paper, 2024 · strength 0.22
- Paper Circulating immune-related proteins associated with immune checkpoint inhibitor efficacy in patients with pancreatic du… DOI 10.1016/j.esmoop.2024.103489 ↗
Troels Dreier Christensen · 1 shared paper, 2024 · strength 0.22
- Paper Circulating immune-related proteins associated with immune checkpoint inhibitor efficacy in patients with pancreatic du… DOI 10.1016/j.esmoop.2024.103489 ↗
Dorte Lisbet Nielsen · 1 shared paper, 2024 · strength 0.22
- Paper Circulating immune-related proteins associated with immune checkpoint inhibitor efficacy in patients with pancreatic du… DOI 10.1016/j.esmoop.2024.103489 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.